Your browser doesn't support javascript.
COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes.
Al-Hatamleh, Mohammad A I; Hatmal, Ma'mon M; Alshaer, Walhan; Rahman, Engku Nur Syafirah E A; Mohd-Zahid, Manali Haniti; Alhaj-Qasem, Dina M; Yean, Chan Yean; Alias, Iskandar Z; Jaafar, Juhana; Ferji, Khalid; Six, Jean-Luc; Uskokovic, Vuk; Yabu, Hiroshi; Mohamud, Rohimah.
  • Al-Hatamleh MAI; Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan, Malaysia.
  • Hatmal MM; Department of Medical Laboratory Sciences, Faculty of Applied Health Sciences, The Hashemite University, P.O. Box 330127, Zarqa, 13133, Jordan.
  • Alshaer W; Cell Therapy Center (CTC), The University of Jordan, Amman, 11942, Jordan.
  • Rahman ENSEA; Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan, Malaysia.
  • Mohd-Zahid MH; Department of Chemical Pathology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan, Malaysia.
  • Alhaj-Qasem DM; Precision Medical Laboratory, Amman, 11954, Jordan.
  • Yean CY; Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan, Malaysia; Hospital Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan, Malaysia.
  • Alias IZ; Department of Chemical Pathology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan, Malaysia; Hospital Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan, Malaysia.
  • Jaafar J; Advanced Membrane Technology Research Centre (AMTEC), School of Chemical and Energy Engineering, Faculty of Engineering, Universiti Teknologi Malaysia, Skudai, 81310, Johor, Malaysia.
  • Ferji K; Université de Lorraine, CNRS, LCPM, F-5400, Nancy, France.
  • Six JL; Université de Lorraine, CNRS, LCPM, F-5400, Nancy, France.
  • Uskokovic V; TardigradeNano LLC, Irvine, CA, 92604, USA.
  • Yabu H; WPI-Advanced Institute for Materials Research (AIMR), Tohoku University, 2-1-1, Katahira, Aoba-Ku, Sendai, 980-8577, Japan.
  • Mohamud R; Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan, Malaysia; Hospital Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan, Malaysia. Electronic address: rohimahm@usm.my.
Eur J Pharmacol ; 896: 173930, 2021 Apr 05.
Article in English | MEDLINE | ID: covidwho-1139488
ABSTRACT
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which emerged in December 2019 and caused the coronavirus disease 2019 (COVID-19) pandemic, took the world by surprise with an unprecedented public health emergency. Since this pandemic began, extraordinary efforts have been made by scientists to understand the pathogenesis of COVID-19, and to fight the infection by providing various preventive, diagnostic and treatment opportunities based on either novel hypotheses or past experiences. Despite all the achievements, COVID-19 continues to be an accelerating health threat with no specifically approved vaccine or therapy. This review highlights the recent advances in COVID-19 infection, with a particular emphasis on nanomedicine applications that can help in the development of effective vaccines or therapeutics against COVID-19. A novel future perspective has been proposed in this review based on utilizing polymersome nano-objects for effectively suppressing the cytokine storm, which may reduce the severity of COVID-19 infection.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Viral Vaccines / Nanomedicine / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Observational study / Prognostic study / Qualitative research Topics: Vaccines Limits: Humans Language: English Journal: Eur J Pharmacol Year: 2021 Document Type: Article Affiliation country: J.ejphar.2021.173930

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Viral Vaccines / Nanomedicine / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Observational study / Prognostic study / Qualitative research Topics: Vaccines Limits: Humans Language: English Journal: Eur J Pharmacol Year: 2021 Document Type: Article Affiliation country: J.ejphar.2021.173930